| Literature DB >> 31399520 |
Ameer Ali Bohio1,2, Aman Sattout1,2, Ruoxi Wang1,2, Ke Wang1,2, Rajiv Kumar Sah3, Xiaolan Guo1,2, Xianlu Zeng1,2, Yueshuang Ke1,2, Istvan Boldogh4, Xueqing Ba5,2.
Abstract
Poly(ADP-ribosyl)ation is a rapid and transient posttranslational protein modification mostly catalyzed by poly(ADP-ribose) polymerase-1 (PARP1). Fundamental roles of activated PARP1 in DNA damage repair and cellular response pathways are well established; however, the precise mechanisms by which PARP1 is activated independent of DNA damage, and thereby playing a role in expression of inflammatory genes, remain poorly understood. In this study, we show that, in response to LPS or TNF-α exposure, the nonreceptor tyrosine kinase c-Abl undergoes nuclear translocation and interacts with and phosphorylates PARP1 at the conserved Y829 site. Tyrosine-phosphorylated PARP1 is required for protein poly(ADP-ribosyl)ation of RelA/p65 and NF-κB-dependent expression of proinflammatory genes in murine RAW 264.7 macrophages, human monocytic THP1 cells, or mouse lungs. Furthermore, LPS-induced airway lung inflammation was reduced by inhibition of c-Abl activity. The present study elucidated a novel signaling pathway to activate PARP1 and regulate gene expression, suggesting that blocking the interaction of c-Abl with PARP1 or pharmaceutical inhibition of c-Abl may improve the outcomes of PARP1 activation-mediated inflammatory diseases.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31399520 PMCID: PMC6731455 DOI: 10.4049/jimmunol.1801616
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422